Real-World Evidence Unlock the Power of Swedish Register Data

Swedish registers offer unmatched opportunities for real-world evidence studies on treatment effectiveness, safety, and health outcomes – but navigating them requires specialist expertise. At Red Door Analytics, we combine deep expertise in biostatistics and epidemiology with unparalleled knowledge of Nordic registers to deliver rigorous, publication-quality RWE studies from concept through completion.

Ready to discuss your Swedish register study?

Let’s discuss your research goals! Schedule a meeting with us via our contact form or RFI/RFP form.

Explore Our Real-World Evidence Services

Learn more about our approach

Why Swedish Registers?

Sweden offers researchers a unique advantage: comprehensive national registries with population-level data spanning decades. The register infrastructure includes both medical registers (capturing healthcare utilization, diagnoses, treatments, and outcomes—some dating back over 60 years) and sociodemographic registers (covering demographics, education, employment, and social factors). All registers are linkable at the individual level using the Swedish national ID number, enabling comprehensive analyses across Sweden’s population of 10 million. This rich data infrastructure makes Sweden an exceptional setting for robust, real-world research in clinical, epidemiological, and health economic applications.

Besides the national registers, Sweden has around 150 disease-specific registers which include information on diagnostic variables, genetic traits, treatments, and follow-up data. Using the Swedish national ID number each register can be linked to all national registers or other quality registers. To assure a high quality and coverage each quality register is annually reviewed by the Swedish national authorities and assigned a certified quality level ranging from three (lowest) to one (highest). Level one quality registers are required to have a coverage of at least 85%.

Exemplar quality registers in Sweden

Oncology/Haematology

  • Prostate cancer
  • Breast cancer
  • Lung cancer
  • Colorectal cancer
  • Lymphoma

Cardiovascular disease

  • Acute myocardial infarction
  • Vascular surgery
  • Stroke

Other diseases

  • Diabetes
  • Kidney diseases
  • Inflammatory bowel diseases
  • Assisted reproductive techniques

Our End-to-End Service

We provide end-to-end support for your Swedish registry studies, from initial planning and ethics applications through to statistical analysis and publication. Our team has substantial experience working with Swedish register data across multiple disease areas including haematology, oncology, hepatology, and cardiology. Our RWE studies have led to publications in high-impact journals such as the European Heart Journal, Leukemia, and the British Journal of Dermatology.

Our Commitment to Quality

All our studies follow standardized operating procedures and rigorous processes to ensure that they meet the highest quality standards:

  • Multi-level quality control and independent validation
  • Fully reproducible analyses with documented workflows
  • Thorough documentation at every stage of the project

Our Experts

Meet our Swedish register specialists who will guide your study from concept to publication.

Dr Hannah Bower brings extensive expertise in register-based epidemiological research and advanced survival analysis methodology. With a strong publication record spanning haematology, oncology, rheumatology, and nephrology, she has consistently produced high-impact research translating sophisticated statistical approaches into clinically meaningful insights. Her expertise in flexible parametric survival models, data linkage, and pharmacoepidemiology enables her to lead complex real-world evidence projects from conception to publication.

Dr Hannah Bower
Director of Applied Biostatistics

 

Dr Sara Ekberg has over 15 years’ experience conducting studies using Swedish register data. She has led complex and advanced analyses across multiple therapeutic areas including haematology, oncology, and cardiology, resulting in numerous high-impact publications. Her deep expertise in navigating Swedish national and quality registries, combined with her rigorous knowledge of advanced statistical methods, ensures robust study design and execution for real-world evidence research.

Dr Sara Ekberg
Associate Director
of Applied Biostatistics

 

During his time at Karolinska Institutet, Dr Joshua Entrop established a comprehensive data linkage of approximately 45,000 lymphoma patients, 450,000 matched comparators, and their first-degree relatives using Swedish registers. His extensive hands-on experience with Swedish registry data, combined with his expertise in causal inference methods and keen interest in reproducible research, provides a strong foundation for delivering rigorous and impactful real-world evidence studies.
Dr Joshua Entrop
Biostatistician